Jair Manuel Gutiérrez Herrera

Dr. Jair Manuel Gutiérrez Herrera

Pathology and Cancer Diagnostic, Karolinska University Hospital, Stockholm, Sweden
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2007 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
MMMiguel Martorell
Miguel Martorell
APAna Pérez-Vallés
Ana Pérez-Vallés
FGFrancisco Gozalbo
Francisco Gozalbo
JGJOSE ANGEL GARCIA GARCIA
JOSE ANGEL GARCIA GARCIA
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera
JGJohn Gaona
John Gaona
Background: Extrapleural Solitary Fibrous tumors (SFTs) have been increasingly reported. The retroperitoneum, deep soft tissues of proximal extremities, abdominal cavity, trunk, head and neck are the most common extraserosal locations reported. Microscopically they show a wide range of morphological features, and so the differential diagnosis is extensive. Immunohistochemically, they commonly express CD34, vimentin, bcl-2 and CD99. Epithelial membrane antigen (EMA) and smooth muscle actin (SMA) may occasionally be expressed. Epithelioid morphology in extrapleural SFT has only very occasionally been described (five cases reported), some of them with biphasic pattern and others with malignant characteristics. Case presentation: A SFT of the thigh with epithelioid areas in a 63 year old woman is reported. Microscopically the tumor showed areas hypo and hipercellular. At the periphery of the hipercellular areas there were nodules composed of epithelioid cells. Immunohistochemically both the spindle and epithelioid cells were positive for CD34, vimentin, bcl-2 and CD99. Epithelial, neural and muscular markers were negative. Molecular study was done and ruled out a synovial sarcoma. Conclusion: Ten cases of SFT of the thigh have been reported but to our knowledge this is the first case with epithelioid morphology affecting the extremities. Identification of this pattern of SFT is of importance, to avoid misdiagnosis with other more aggressive conditions in soft tissue.

1 August 2008 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
MMMiguel Martorell
Miguel Martorell
JMJohn Jairo Gaona Morales
John Jairo Gaona Morales
JGJOSE ANGEL GARCIA GARCIA
JOSE ANGEL GARCIA GARCIA
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera
FGFrancisco Gozalbo Grau
Francisco Gozalbo Grau
AVAna Pérez Vallés
Ana Pérez Vallés

25 February 2008 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
LGL. G. González-Bonet
L. G. González-Bonet
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera
JGJ. M. Gallego
J. M. Gallego
JBJ. A. Barcia
J. A. Barcia

1 November 2012 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
AOAngela Ortiz Otero
Angela Ortiz Otero
IVInmaculada de Prada Vicente
Inmaculada de Prada Vicente
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera
DCDaniel Azorín Cuadrilleros
Daniel Azorín Cuadrilleros

1 July 2009 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
CGCarmen García-Navalon
Carmen García-Navalon
MCMiguel Armengot Carceller
Miguel Armengot Carceller
VMVicente Sabater Marco
Vicente Sabater Marco
RFRosa Ma Reboll Ferrer
Rosa Ma Reboll Ferrer
SMSoledad Frías Moya-Angeler
Soledad Frías Moya-Angeler
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera

27 February 2025 in Journal of Respiration
Verified
Journal Article
Open access
PDF file
JHJair Manuel Gutiérrez Herrera
Jair Manuel Gutiérrez Herrera
MMM.Angeles Montero-Fernandez
M.Angeles Montero-Fernandez
GKGeorgia Kokaraki
Georgia Kokaraki
LPLuigi De Petris
Luigi De Petris
RFRaul Falcao
Raul Falcao
COCristian Ortiz-Villalón
Cristian Ortiz-Villalón
Background/Objectives: Since the discovery of oncogenic neurotrophic receptor tyrosine kinase (NTRK) gene fusions in colorectal cancer in 1986, their understanding has evolved, particularly in non-small-cell lung cancer (NSCLC) over the past five years. NTRK rearrangements, involving NTRK1, NTRK2, and NTRK3, drive tumorigenesis and have been identified in various adult and pediatric cancers, with over 80 different fusion variants in several type of cancers. Detecting these rearrangements is crucial for targeted therapy strategies. The aim of this study is detect, compare and analyse these mutations in NSCLC patients of a cohort of 482 cases from Karolinska University Hospital. Methods: We conducted an initial screening using pan-TRK immunohistochemistry (IHC) to analyze the material. Positive cases were further examined through whole-exome sequencing (WES) with next-generation sequencing (NGS) to confirm the presence of fusions. Additionally, to deepen our understanding, we utilized Ingenuity Pathway Analysis (IPA) software, an artificial intelligence-driven technology, to explore the molecular pathways involved in lung cancer. Results: TRK overexpression was detected in 4.56% of cases via IHC. Among 15 pan-TRK-positive cases, WES confirmed fusions in 3, revealing a higher prevalence of NTRK1 (6.6%) and NTRK2 (13.3%) fusions, while no NTRK3 fusions were observed. Conclusions: Our findings confirm the low prevalence of these neoplasms as well as the need for a molecular test to confirm rearrangements or other potentially treatable mutations and raise other questions regarding their clinical use. However, there is an acceptable correlation between pan-TRK IHC and NTRK mutations, but not enough to determine NTRK fusions.